Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
765.48
937.20
1,193.75
1,369.25
934.25
1,163.46
874.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
765.48
937.20
1,193.75
1,369.25
934.25
1,163.46
874.02
Raw Material Cost
117.54
120.84
139.66
140.15
106.89
124.59
124.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
251.66
261.47
250.79
298.04
143.24
167.53
200.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.72
3.52
1.95
1.43
6.70
7.47
7.95
Selling and Distribution Expenses
340.23
475.28
667.80
767.09
526.04
639.45
550.85
Other Expenses
5.69
-1.58
-0.43
-4.36
-0.52
-4.42
-8.89
Total Expenditure (Excl Depreciation)
767.03
845.33
1,055.89
1,163.07
777.64
894.87
794.86
Operating Profit (PBDIT) excl Other Income
-1.6
91.89999999999999
137.89999999999998
206.20000000000002
156.6
268.6
79.2
Other Income
50.24
57.92
48.98
60.26
54.92
39.49
50.42
Operating Profit (PBDIT)
131.01
211.63
276.27
338.51
269.82
368.27
194.21
Interest
0.72
3.52
1.95
1.43
6.70
7.47
7.95
Exceptional Items
-4.27
-5.56
-1.17
-0.42
0.00
-5.99
-7.78
Gross Profit (PBDT)
647.93
816.37
1,054.08
1,229.11
827.36
1,038.86
749.64
Depreciation
89.14
68.77
95.58
74.49
61.63
67.66
67.27
Profit Before Tax
36.88
133.78
177.56
262.16
201.50
287.14
111.21
Tax
-36.84
-12.07
-5.79
4.27
13.98
29.09
3.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
43.08
120.03
160.47
257.07
185.03
257.80
132.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
43.08
120.03
160.47
257.07
185.03
257.80
132.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.33
-0.20
-0.84
-1.10
-0.45
-7.60
-25.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.76
119.84
159.63
255.96
184.58
250.20
107.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.11
0.11
0.11
0.12
0.12
0.11
0.11
Reserves
2,452.55
2,595.68
2,534.14
2,682.56
2,384.24
1,042.00
1,075.61
Earnings per share (EPS)
0.04
0.12
0.16
0.25
0.19
0.28
0.14
Diluted Earnings per share
0.04
0.12
0.16
0.25
0.19
0.28
0.14
Operating Profit Margin (Excl OI)
-1.09%
9.06%
11.03%
14.88%
16.41%
22.44%
8.75%
Gross Profit Margin
16.46%
21.61%
22.88%
24.59%
28.16%
30.5%
20.42%
PAT Margin
5.63%
12.81%
13.44%
18.77%
19.81%
22.16%
15.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -18.32% vs -21.49% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -64.27% vs -24.94% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -47.43% vs -32.38% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -80.00% vs 75.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
765.48
5,721.40
-4,955.92
-86.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
765.48
5,721.40
-4,955.92
-86.62%
Raw Material Cost
117.54
3,926.23
-3,808.69
-97.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
251.66
0.00
251.66
Power Cost
0
0
0.00
Manufacturing Expenses
0.72
166.42
-165.70
-99.57%
Selling and Distribution Expenses
340.23
781.35
-441.12
-56.46%
Other Expenses
5.69
5.44
0.25
4.60%
Total Expenditure (Excl Depreciation)
767.03
4,928.43
-4,161.40
-84.44%
Operating Profit (PBDIT) excl Other Income
-1.56
792.97
-794.53
-100.20%
Other Income
50.24
383.33
-333.09
-86.89%
Operating Profit (PBDIT)
131.01
1,518.99
-1,387.98
-91.38%
Interest
0.72
166.42
-165.70
-99.57%
Exceptional Items
-4.27
-41.39
37.12
89.68%
Gross Profit (PBDT)
647.93
1,795.17
-1,147.24
-63.91%
Depreciation
89.14
370.02
-280.88
-75.91%
Profit Before Tax
36.88
941.16
-904.28
-96.08%
Tax
-36.84
109.84
-146.68
-133.54%
Provisions and contingencies
0
0
0.00
Profit After Tax
43.08
701.21
-658.13
-93.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
43.08
701.21
-658.13
-93.86%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.33
-23.66
23.33
98.61%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.76
677.55
-634.79
-93.69%
Equity Capital
0
0
0.00
Face Value
0.11
1.06
0.00
Reserves
2,452.55
12,928.76
-10,476.21
-81.03%
Earnings per share (EPS)
0.04
0.48
-0.44
-91.67%
Diluted Earnings per share
0.04
0.48
-0.44
-91.67%
Operating Profit Margin (Excl OI)
-1.09%
13.38%
0.00
-14.47%
Gross Profit Margin
16.46%
22.92%
0.00
-6.46%
PAT Margin
5.63%
12.26%
0.00
-6.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 76.55 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -18.32% vs -21.49% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 4.28 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -64.27% vs -24.94% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.08 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -47.43% vs -32.38% in Dec 2023
Annual - Interest
Interest 0.07 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -80.00% vs 75.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1.09%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
